While the end of 2013 and the beginning of 2014 saw many speculative pharmaceutical and biotech companies experience immense growth, the recent sector pullback exemplifies the need to select fundamentally strong investments. I have identified Threshold Pharmaceuticals (NASDAQ:THLD) as a stock that traded relatively flat during the past 18 months, but presents an attractive investment in the near and long term.
Threshold Pharmaceuticals was incorporated in 2001, and went public in 2004. THLD is a small-cap pharmaceutical company focused on improving the treatment of various cancers - such as soft-tissues sarcomas (STS), pancreatic cancer, and multiple myeloma - through its therapies, with a unique mechanism of action. The company develops therapies that target the microenvironment of a number...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|